Cardiovascular Disease Solutions September 26, 2025
Breaking Barriers in Coronary Care: Abbott’s New IVL System Targets Severe Calcification September 26, 2025
By: Jennifer Jones-McMeans, PhD , Divisional Vice President of Global Clinical Affairs at AbbottSponsored by Abbott Severe calcification is one of the complex challenges faced by interventional […]
Cholesterol Reduction September 25, 2025
Meds-to-Beds Improve PCSK9 Inhibitor Access and Efficacy September 25, 2025
PCSK9 inhibitors might finally reach their clinical potential in the patients who need them most, after the ELL-ASCVD study demonstrated that a Meds-to-Beds program delivering these medications before hospital discharge significantly improved patient uptake.
Cardiovascular Disease September 22, 2025
OCTOPUS: What Really Causes MI in Younger Patients September 22, 2025
Young heart attack patients might actually be a completely different disease population than previously understood, after the OCTOPUS registry analysis revealed that the causes of early MI and the people who get them aren’t what’s expected.
Cardiology Practices September 18, 2025
What Cardiologists Say vs. What Patients Hear September 18, 2025
Cardiovascular risk communication might be failing patients when they need it most, after the HARIPA study revealed significant disconnects between patient and physician perceptions of future cardiovascular risk and procedural complications.
Digital Health September 15, 2025
TRICORDER Shows Potential of AI Stethoscopes September 15, 2025
Results from the massive TRICORDER study suggest Eko Health's AI-powered stethoscopes could change the way primary care providers perform cardiac screening, potentially catching thousands more patients for cardiologists to treat.
Cardiology September 11, 2025
Cardiac Wire’s ASE 2025 Takeaways September 11, 2025
The American Society of Echocardiography left an echo this year in Music City as it celebrated its 50th year. Among the studies and products unveiled at ASE 2025, here are Cardiac Wire’s top five takeaways from the meeting.
Cardiology Business September 8, 2025
Edwards Acquires Vectorious, Bolsters HF Portfolio September 8, 2025
Edwards Lifesciences took a step towards becoming a major player in remote HF monitoring, after acquiring startup Vectorious.
Cardiology Pharmaceuticals September 4, 2025
The Differences in HCM, Results from ODYSSEY and MAPLE September 4, 2025
In a big step towards better hypertrophic cardiomyopathy treatments, two separate studies presented at ESC suggest cardiac myosin inhibitors’ efficacy depends critically on whether patients have the obstructive or nonobstructive form of the disease.
Cardiology August 28, 2025
Cardiologists, Practice What You Preach! August 28, 2025
Cardiologists might be struggling with the same lifestyle challenges they counsel patients about, as a national survey of ACC members revealed significant gaps between what physicians’ recommend and how they act.
Obesity Care August 25, 2025
GLP-1s Work, But Not for Free August 25, 2025
Real-world semaglutide (Wegovy) patients might be experiencing a healthcare cost paradox, after a recent analysis in JAMA showed that GLP-1s successfully reduce weight and improve cardiovascular risk factors, but lead to increased patient healthcare expenditures in the short term.
Electrophysiology August 21, 2025
Conduction-System Pacing Succeeds at Treating AV Block August 21, 2025
Conduction-system pacing could be poised to reshape standard care for atrioventricular (AV) block patients after the randomized CSPACE trial demonstrated its significant benefits over traditional right ventricular septal pacing.
Cardiology Pharmaceuticals August 18, 2025
Rivaroxaban Monotherapy Could Be Better for CAD + AFib August 18, 2025
New analysis from the AFIRE trial suggests rivaroxaban monotherapy might be emerging as a preferred antithrombotic strategy for patients with AFib and stable coronary artery disease, especially in older age groups.
Surgeries & Interventions August 14, 2025
TEER Could Save Lives in AFMR Patients August 14, 2025
Shedding light on a new treatment for an understudied condition, data published in EHJ suggests that transcatheter edge-to-edge repair (TEER) delivers significant survival advantages in patients with atrial functional mitral regurgitation (FMR).
Cardiology Business August 11, 2025
The State of the TAVR Market in 2025 August 11, 2025
2025 has been a year of many cardiology trends, with one stand out technology capturing much of the spotlight – transcatheter aortic valves. To keep our valves in a row, Cardiac Wire has compiled a breakdown of the top TAVR makers, movers, shakers, and potential future players.
Cardiology Pharmaceuticals August 7, 2025
SURPASS-CVOT Shows Mounjaro Surpasses Trulicity in CV Outcomes August 7, 2025
The largest and longest tirzepatide study to date just confirmed that Eli Lilly’s Mounjaro has surpassed its older GLP-1, Trulicity, in practically every way, with significant gains when it comes to cardiovascular benefits.
Cardiovascular Disease August 4, 2025
The Impact of Physical Activity Before and After CV Events August 4, 2025
A long-term analysis of the CARDIA study revealed that moderate-to-vigorous physical activity steadily declines from young adulthood through midlife, but patients destined to develop cardiovascular disease experience rapid activity decreases more than a decade before their first event.
Cardiology Pharmaceuticals July 31, 2025
AstraZeneca’s Anselamimab Comes Up Short in Phase 3 Trial July 31, 2025
In a setback to one of its rarer disease pipelines, AstraZeneca’s amyloidosis antibody, anselamimab, failed to significantly reduce all-cause mortality and CV hospitalizations in the CARES Phase 3 trial’s overall patient population.
Cardiology Pharmaceuticals July 28, 2025
SGLT2i Prescriptions Increase for HF, With Some Exceptions July 28, 2025
Three years after SGLT2 inhibitors were added to the heart failure treatment guidelines, a JAMA Cardiology study reveals significant new prescriptions, with a few key patient sub-groups falling behind.
Cardiac Imaging July 24, 2025
The Top Trends of SCCT 2025 July 24, 2025
The Society of Cardiovascular Computed Tomography had its 20th annual meeting in the gorgeous city of Montreal and though it's still intimate, the conference punches well above its weight class when it comes to innovation. Here are some of the big takeaways from SCCT 2025.